OmniActive signs exclusive distribution deal in China

Shanghai Prochin has joined forces with OmniActive to market Lutemax 2020 Lutein and Zeaxanthin Isomers in China

Image as seen on OmniActive website

OmniActive Health Technologies has entered into an exclusive distribution partnership in China with Shanghai Prochin. Through its comprehensive distribution reach and relationships with key brands, Shanghai Prochin will market Lutemax 2020 Lutein and Zeaxanthin Isomers to all segments of the nutraceutical industry in China.

Lutemax 2020 is a naturally-derived marigold extract providing all three macular carotenoids—lutein and enhanced levels of both zeaxanthin isomers (RR-and RS [meso]-zeaxanthin)—at the same 5:1 ratio as found naturally in the diet to boost the benefits of eye health formulations.

It has been reported that China may soon become the most significant nutritional supplement market in the world, currently a title held by the US.

"China's 1.4 billion people account for the highest general population on the globe, and with screen time on the rise as well as an increase in life expectancy and changes in diet, the clinically-studied, globally-recognised vision and cognitive health and performance benefits of Lutemax 2020 will fill a much needed nutritional gap," said Johan Kamphuis, President, Global Business, OmniActive Health Technologies.

"We stand confident that combining Shanghai Prochin's capabilities and OmniActive's expertise in innovation and technologies will ensure sustainable growth in this key market," Kamphuis added.

Companies